75 related articles for article (PubMed ID: 9613986)
21. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
22. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Nichols KE; Levitz S; Shannon KE; Wahrer DC; Bell DW; Chang G; Hegde S; Neuberg D; Shafman T; Tarbell NJ; Mauch P; Ishioka C; Haber DA; Diller L
J Clin Oncol; 1999 Apr; 17(4):1259. PubMed ID: 10561187
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic effects of etoposide (VP-16) on human lymphocytes; with special reference to the relation between sister chromatid exchange and chromatid breakage.
Tominaga K; Shinkai T; Saijo N; Nakajima T; Ochi H; Suemasu K
Jpn J Cancer Res; 1986 Apr; 77(4):385-91. PubMed ID: 3084428
[TBL] [Abstract][Full Text] [Related]
24. Sister chromatid exchanges and chromosomes in chronic myelogenous leukemia and cancer families.
Cheng WS; Mulvihill JJ; Greene MH; Pickle LW; Tsai S; Whang-Peng J
Int J Cancer; 1979 Jan; 23(1):8-13. PubMed ID: 282271
[TBL] [Abstract][Full Text] [Related]
25. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract][Full Text] [Related]
26. Management of breast cancer after Hodgkin's disease.
Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
[TBL] [Abstract][Full Text] [Related]
28. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
29. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to Hodgkin's lymphoma and to secondary cancer: workshop report.
Staratschek-Jox A; Shugart YY; Strom SS; Nagler A; Taylor GM
Ann Oncol; 2002; 13 Suppl 1():30-3. PubMed ID: 12078899
[TBL] [Abstract][Full Text] [Related]
31. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
[TBL] [Abstract][Full Text] [Related]
32. Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy.
Sardaş S; Erdoğan F; Sardaş OS; Cengel M; Karakaya AE
Anticancer Drugs; 1994 Aug; 5(4):487-9. PubMed ID: 7524801
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
35. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
[TBL] [Abstract][Full Text] [Related]
36. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Biegel JA; Conner MK; Boggs SS
Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
[TBL] [Abstract][Full Text] [Related]
37. Progress towards understanding the nature of chromatid breakage.
Bryant PE; Gray LJ; Peresse N
Cytogenet Genome Res; 2004; 104(1-4):65-71. PubMed ID: 15162016
[TBL] [Abstract][Full Text] [Related]
38. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
39. Sister chromatid exchange assessment by chromosome orientation-fluorescence in situ hybridization on the bovine sex chromosomes and autosomes 16 and 26.
Revay T; King WA
Cytogenet Genome Res; 2012; 136(2):107-16. PubMed ID: 22286126
[TBL] [Abstract][Full Text] [Related]
40. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
